The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of circulating tumor DNA (ctDNA) dynamics with clinical response in muscle-invasive bladder cancer (MIBC) patients (pts) undergoing trimodality therapy (TMT).
 
Ilana Epstein
No Relationships to Disclose
 
Adetolani Odogiyon
No Relationships to Disclose
 
Stephanie Berg
Honoraria - Aptitude Health; Curio Science
Consulting or Advisory Role - Eisai; Exelixis; Guardant Health; Natera; Pfizer; Zencor
 
Yukako Otani
No Relationships to Disclose
 
Charlene Mantia
Consulting or Advisory Role - AADi; Cogent Biosciences; EMD Serono; Nextech; Synthekine
Research Funding - Bristol-Myers Squibb (Inst)
 
Isabella Pompa
No Relationships to Disclose
 
Matthew Mossanen
Consulting or Advisory Role - Elsevier
Other Relationship - Elsevier
 
Joshua Wan
No Relationships to Disclose
 
Anurag Saraf
Employment - Brigham and Womens Hospital
 
Arvind Ravi
Stock and Other Ownership Interests - Halo Pharma
Consulting or Advisory Role - Halo Pharma; IBM (Inst); Tegus
 
Filipe Carvalho
No Relationships to Disclose
 
Daniel Roberts
Employment - Roslindale Pediatrics Associates (I)
 
Luke Peng
Employment - Brigham and Women's Hospital
 
Bradley McGregor
Consulting or Advisory Role - Arcus Biosciences; Astellas Pharma; AVEO; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; Exelixis; Genmab; Gilead Sciences; Hexagon; Loxo/Lilly; Pfizer; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Pfizer/EMD Serono (Inst); Seattle Genetics/Astellas (Inst)
 
Joaquim Bellmunt
Stock and Other Ownership Interests - Rainier Therapeutics
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono/Merck; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Pfizer/EMD Serono (Inst); Pfizer/Gilead
Patents, Royalties, Other Intellectual Property - UpToDate Bladder Cancer
Travel, Accommodations, Expenses - Genentech/Roche; Ipsen
 
Sophia Kamran
Employment - Sanofi (I)
Honoraria - Medscape; Varian Medical Systems
 
Jacob Berchuck
Stock and Other Ownership Interests - Cityblock Health (I); Genome Medical; Musculo; Oncotect; Precede Bio; TracerDx
Honoraria - Guardant Health
Consulting or Advisory Role - Genome Medical; Guardant Health; Musculo; Oncotect; Precede Bio; TracerDx
Speakers' Bureau - Guardant Health
Research Funding - Guardant Health (Inst); Precede Bio (Inst)
Patents, Royalties, Other Intellectual Property - Institutional patent filed on methods for detecting prostate cancer resistance using cell-free DNA
Travel, Accommodations, Expenses - Guardant Health
 
Jason Efstathiou
Honoraria - Elekta; IBA
Consulting or Advisory Role - AngioDynamics; AstraZeneca; Bayer; Blue Earth Diagnostics; Blue Earth Diagnostics; Boston Scientific; Genentech; Gilead Sciences; Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences; Pfizer; Progenics
 
David Miyamoto
No Relationships to Disclose
 
Kent Mouw
Stock and Other Ownership Interests - Riva Therapeutics
Honoraria - OncLive/MJH Life Sciences; UpToDate
Consulting or Advisory Role - Natera; Pfizer; Riva Therapeutics; Urogen pharma
Research Funding - Pfizer
Patents, Royalties, Other Intellectual Property - Institutional patent filed on mutational signatures of DNA repair deficiency